Cargando…
The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations
The aim of this study was to compare various formulations solid dispersion pellets (SDP), nanostructured lipid carriers (NLCs) and a self-microemulsifying drug delivery system (SMEDDS) generally accepted to be the most efficient drug delivery systems for BCS II drugs using fenofibrate (FNB) as a mod...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180958/ https://www.ncbi.nlm.nih.gov/pubmed/25248304 http://dx.doi.org/10.1186/s12951-014-0039-3 |
_version_ | 1782337293869121536 |
---|---|
author | Weng, Tengfei Qi, Jianping Lu, Yi Wang, Kai Tian, Zhiqiang Hu, Kaili Yin, Zongning Wu, Wei |
author_facet | Weng, Tengfei Qi, Jianping Lu, Yi Wang, Kai Tian, Zhiqiang Hu, Kaili Yin, Zongning Wu, Wei |
author_sort | Weng, Tengfei |
collection | PubMed |
description | The aim of this study was to compare various formulations solid dispersion pellets (SDP), nanostructured lipid carriers (NLCs) and a self-microemulsifying drug delivery system (SMEDDS) generally accepted to be the most efficient drug delivery systems for BCS II drugs using fenofibrate (FNB) as a model drug. The size and morphology of NLCs and SMEDDS was characterized by dynamic light scattering (DLS) and transmission electron microscopy (TEM). Their release behaviors were investigated in medium with or without pancreatic lipase. The oral bioavailability of the various formulations was compared in beagle dogs using commercial Lipanthyl® capsules (micronized formulation) as a reference. The release of FNB from SDP was much faster than that from NLCs and SMEDDS in medium without lipase, whereas the release rate from NLCs and SMEDDS was increased after adding pancreatic lipase into the release medium. However, NLCs and SMEDDS increased the bioavailability of FNB to 705.11% and 809.10%, respectively, in comparison with Lipanthyl® capsules, although the relative bioavailability of FNB was only 366.05% after administration of SDPs. Thus, lipid-based drug delivery systems (such as NLCs and SMEDDS) may have more advantages than immediate release systems (such as SDPs and Lipanthyl® capsules). |
format | Online Article Text |
id | pubmed-4180958 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41809582014-10-14 The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations Weng, Tengfei Qi, Jianping Lu, Yi Wang, Kai Tian, Zhiqiang Hu, Kaili Yin, Zongning Wu, Wei J Nanobiotechnology Research The aim of this study was to compare various formulations solid dispersion pellets (SDP), nanostructured lipid carriers (NLCs) and a self-microemulsifying drug delivery system (SMEDDS) generally accepted to be the most efficient drug delivery systems for BCS II drugs using fenofibrate (FNB) as a model drug. The size and morphology of NLCs and SMEDDS was characterized by dynamic light scattering (DLS) and transmission electron microscopy (TEM). Their release behaviors were investigated in medium with or without pancreatic lipase. The oral bioavailability of the various formulations was compared in beagle dogs using commercial Lipanthyl® capsules (micronized formulation) as a reference. The release of FNB from SDP was much faster than that from NLCs and SMEDDS in medium without lipase, whereas the release rate from NLCs and SMEDDS was increased after adding pancreatic lipase into the release medium. However, NLCs and SMEDDS increased the bioavailability of FNB to 705.11% and 809.10%, respectively, in comparison with Lipanthyl® capsules, although the relative bioavailability of FNB was only 366.05% after administration of SDPs. Thus, lipid-based drug delivery systems (such as NLCs and SMEDDS) may have more advantages than immediate release systems (such as SDPs and Lipanthyl® capsules). BioMed Central 2014-09-24 /pmc/articles/PMC4180958/ /pubmed/25248304 http://dx.doi.org/10.1186/s12951-014-0039-3 Text en © Weng et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Weng, Tengfei Qi, Jianping Lu, Yi Wang, Kai Tian, Zhiqiang Hu, Kaili Yin, Zongning Wu, Wei The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations |
title | The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations |
title_full | The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations |
title_fullStr | The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations |
title_full_unstemmed | The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations |
title_short | The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations |
title_sort | role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a bcs ii drug: comparison with fast-release formulations |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180958/ https://www.ncbi.nlm.nih.gov/pubmed/25248304 http://dx.doi.org/10.1186/s12951-014-0039-3 |
work_keys_str_mv | AT wengtengfei theroleoflipidbasednanodeliverysystemsonoralbioavailabilityenhancementoffenofibrateabcsiidrugcomparisonwithfastreleaseformulations AT qijianping theroleoflipidbasednanodeliverysystemsonoralbioavailabilityenhancementoffenofibrateabcsiidrugcomparisonwithfastreleaseformulations AT luyi theroleoflipidbasednanodeliverysystemsonoralbioavailabilityenhancementoffenofibrateabcsiidrugcomparisonwithfastreleaseformulations AT wangkai theroleoflipidbasednanodeliverysystemsonoralbioavailabilityenhancementoffenofibrateabcsiidrugcomparisonwithfastreleaseformulations AT tianzhiqiang theroleoflipidbasednanodeliverysystemsonoralbioavailabilityenhancementoffenofibrateabcsiidrugcomparisonwithfastreleaseformulations AT hukaili theroleoflipidbasednanodeliverysystemsonoralbioavailabilityenhancementoffenofibrateabcsiidrugcomparisonwithfastreleaseformulations AT yinzongning theroleoflipidbasednanodeliverysystemsonoralbioavailabilityenhancementoffenofibrateabcsiidrugcomparisonwithfastreleaseformulations AT wuwei theroleoflipidbasednanodeliverysystemsonoralbioavailabilityenhancementoffenofibrateabcsiidrugcomparisonwithfastreleaseformulations AT wengtengfei roleoflipidbasednanodeliverysystemsonoralbioavailabilityenhancementoffenofibrateabcsiidrugcomparisonwithfastreleaseformulations AT qijianping roleoflipidbasednanodeliverysystemsonoralbioavailabilityenhancementoffenofibrateabcsiidrugcomparisonwithfastreleaseformulations AT luyi roleoflipidbasednanodeliverysystemsonoralbioavailabilityenhancementoffenofibrateabcsiidrugcomparisonwithfastreleaseformulations AT wangkai roleoflipidbasednanodeliverysystemsonoralbioavailabilityenhancementoffenofibrateabcsiidrugcomparisonwithfastreleaseformulations AT tianzhiqiang roleoflipidbasednanodeliverysystemsonoralbioavailabilityenhancementoffenofibrateabcsiidrugcomparisonwithfastreleaseformulations AT hukaili roleoflipidbasednanodeliverysystemsonoralbioavailabilityenhancementoffenofibrateabcsiidrugcomparisonwithfastreleaseformulations AT yinzongning roleoflipidbasednanodeliverysystemsonoralbioavailabilityenhancementoffenofibrateabcsiidrugcomparisonwithfastreleaseformulations AT wuwei roleoflipidbasednanodeliverysystemsonoralbioavailabilityenhancementoffenofibrateabcsiidrugcomparisonwithfastreleaseformulations |